ES2697898T8 - Compuestos triazólicos tricíclicos - Google Patents
Compuestos triazólicos tricíclicosInfo
- Publication number
- ES2697898T8 ES2697898T8 ES15733736T ES15733736T ES2697898T8 ES 2697898 T8 ES2697898 T8 ES 2697898T8 ES 15733736 T ES15733736 T ES 15733736T ES 15733736 T ES15733736 T ES 15733736T ES 2697898 T8 ES2697898 T8 ES 2697898T8
- Authority
- ES
- Spain
- Prior art keywords
- tricyclic
- compounds
- tricyclic compounds
- tricyclic tricyclic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14382254.2A EP2963041A1 (en) | 2014-07-02 | 2014-07-02 | Tricyclic triazolic compounds |
| PCT/EP2015/065063 WO2016001345A1 (en) | 2014-07-02 | 2015-07-02 | Tricyclic triazolic compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2697898T3 ES2697898T3 (es) | 2019-01-29 |
| ES2697898T8 true ES2697898T8 (es) | 2019-02-15 |
Family
ID=51167834
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES15733736T Active ES2697898T3 (es) | 2014-07-02 | 2015-07-02 | Compuestos triazólicos tricíclicos |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10035805B2 (es) |
| EP (2) | EP2963041A1 (es) |
| JP (1) | JP6676252B2 (es) |
| KR (1) | KR20170024026A (es) |
| CN (1) | CN106852143B (es) |
| AU (1) | AU2015282941A1 (es) |
| BR (1) | BR112016030837A2 (es) |
| CA (1) | CA2953737A1 (es) |
| ES (1) | ES2697898T3 (es) |
| IL (1) | IL249907A0 (es) |
| MX (1) | MX2017000048A (es) |
| PH (1) | PH12017500005A1 (es) |
| PT (1) | PT3164403T (es) |
| RU (1) | RU2017103508A (es) |
| SG (1) | SG11201610890PA (es) |
| TN (1) | TN2016000582A1 (es) |
| WO (1) | WO2016001345A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109180499B (zh) * | 2018-07-31 | 2021-04-30 | 上海博志研新药物技术有限公司 | 甲磺酸雷沙吉兰及其中间体的制备方法 |
| CN111718250B (zh) * | 2020-06-28 | 2022-04-22 | 万华化学集团股份有限公司 | 一种制备r-香茅醛的方法 |
| WO2024105225A1 (en) | 2022-11-18 | 2024-05-23 | Universitat De Barcelona | Synergistic combinations of a sigma receptor 1 (s1r) antagonist and a soluble epoxide hydrolase inhibitor (sehi) and their use in the treatment of pain |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1634873A1 (en) | 2004-08-27 | 2006-03-15 | Laboratorios Del Dr. Esteve, S.A. | Sigma receptor inhibitors |
| EP1829869A1 (en) | 2006-03-02 | 2007-09-05 | Laboratorios Del Dr. Esteve, S.A. | 4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands |
| EP1847542A1 (en) | 2006-04-21 | 2007-10-24 | Laboratorios del Dr. Esteve S.A. | Spiro[benzopyran] or spiro[benzofuran] derivatives which inhibit the sigma receptor |
| EP2070933A1 (en) * | 2007-12-07 | 2009-06-17 | Laboratorios del Dr. Esteve S.A. | Tricyclic triazolic compounds |
-
2014
- 2014-07-02 EP EP14382254.2A patent/EP2963041A1/en not_active Withdrawn
-
2015
- 2015-07-02 US US15/323,228 patent/US10035805B2/en not_active Expired - Fee Related
- 2015-07-02 CN CN201580042970.0A patent/CN106852143B/zh not_active Expired - Fee Related
- 2015-07-02 WO PCT/EP2015/065063 patent/WO2016001345A1/en active Application Filing
- 2015-07-02 KR KR1020177002173A patent/KR20170024026A/ko unknown
- 2015-07-02 AU AU2015282941A patent/AU2015282941A1/en not_active Abandoned
- 2015-07-02 SG SG11201610890PA patent/SG11201610890PA/en unknown
- 2015-07-02 TN TN2016000582A patent/TN2016000582A1/en unknown
- 2015-07-02 CA CA2953737A patent/CA2953737A1/en not_active Abandoned
- 2015-07-02 PT PT15733736T patent/PT3164403T/pt unknown
- 2015-07-02 BR BR112016030837A patent/BR112016030837A2/pt not_active IP Right Cessation
- 2015-07-02 EP EP15733736.1A patent/EP3164403B8/en not_active Not-in-force
- 2015-07-02 MX MX2017000048A patent/MX2017000048A/es unknown
- 2015-07-02 ES ES15733736T patent/ES2697898T3/es active Active
- 2015-07-02 JP JP2016575730A patent/JP6676252B2/ja not_active Expired - Fee Related
- 2015-07-02 RU RU2017103508A patent/RU2017103508A/ru not_active Application Discontinuation
-
2017
- 2017-01-02 IL IL249907A patent/IL249907A0/en unknown
- 2017-01-03 PH PH12017500005A patent/PH12017500005A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017103508A3 (es) | 2019-01-11 |
| US20170313710A1 (en) | 2017-11-02 |
| US10035805B2 (en) | 2018-07-31 |
| CN106852143A (zh) | 2017-06-13 |
| IL249907A0 (en) | 2017-03-30 |
| CA2953737A1 (en) | 2016-01-07 |
| AU2015282941A1 (en) | 2017-02-02 |
| PT3164403T (pt) | 2018-11-21 |
| PH12017500005A1 (en) | 2017-05-15 |
| JP6676252B2 (ja) | 2020-04-08 |
| CN106852143B (zh) | 2019-07-16 |
| ES2697898T3 (es) | 2019-01-29 |
| MX2017000048A (es) | 2017-04-27 |
| JP2017519788A (ja) | 2017-07-20 |
| EP2963041A1 (en) | 2016-01-06 |
| EP3164403A1 (en) | 2017-05-10 |
| WO2016001345A1 (en) | 2016-01-07 |
| BR112016030837A2 (pt) | 2017-08-22 |
| EP3164403B1 (en) | 2018-08-29 |
| KR20170024026A (ko) | 2017-03-06 |
| TN2016000582A1 (en) | 2018-04-04 |
| SG11201610890PA (en) | 2017-01-27 |
| RU2017103508A (ru) | 2018-08-02 |
| EP3164403B8 (en) | 2018-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3209778T3 (da) | Kombination | |
| DK3183051T3 (da) | Væske-til-luftmembranenergivekslere | |
| DK3134402T3 (da) | 4-amino-imidazoquinolinforbindelser | |
| DK3211743T3 (da) | Ø-til-netværk-omskiftningsfremgangsmåde | |
| DK3222714T3 (da) | Phytasemutanter | |
| DK3119396T3 (da) | Muscarinreceptoragonister | |
| DK3006072T3 (da) | Karadgang | |
| FIC20230016I1 (fi) | Nirsevimabi | |
| CL2016002165A1 (es) | Compuestos de aminocarbonilcarbamato | |
| DK3157926T3 (da) | Organiske forbindelser | |
| DK3177624T3 (da) | Imidazopyridazinforbindelser | |
| DE112015001664A5 (de) | Betätigungsaktuator | |
| BR112016030730A2 (pt) | Composto | |
| DK3183340T3 (da) | Termolabile exonukleaser | |
| DK3191466T3 (da) | Azetidinyloxyphenylpyrrolidinforbindelser | |
| DK3183242T3 (da) | Substituerede bicykliske forbindelser | |
| DK3154703T3 (da) | Fuldkappe-snekkecentrifuge | |
| DK3110439T3 (da) | Pcsk9-vacciner | |
| DE112015005041A5 (de) | Gargerätevorrichtung | |
| FR3030184B1 (fr) | Derouleuse-pailleuse | |
| DE102014000623A8 (de) | Halbhohlnietelement | |
| ES2697898T8 (es) | Compuestos triazólicos tricíclicos | |
| DK3009858T3 (da) | Skyradar | |
| DE112015001633A5 (de) | Betätigungsaktuator | |
| DK3447493T3 (da) | Proteinrettede ortologer |